News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Kowalsky Matthew Paul
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/11/2023 |
4
| Kowalsky Matthew Paul (CHIEF OF STAFF AND CLO) has filed a Form 4 on Sigilon Therapeutics, Inc.|
Txns:
| Disposed/sold 1,925 shares
@ $0
Disposed/sold 12,690 options to buy
@ $0.75, valued at
$9.5k
|
|
| 03/01/2023 |
4
| Kowalsky Matthew Paul (CHIEF OF STAFF AND CLO) has filed a Form 4 on Sigilon Therapeutics, Inc.|
Txns:
| Granted 165,000 options to buy
@ $1.09, valued at
$179.9k
|
|
| 03/01/2023 |
3
| Kowalsky Matthew Paul (CHIEF OF STAFF AND CLO) has filed a Form 3 on Sigilon Therapeutics, Inc. |
| 01/23/2019 |
4
| Kowalsky Matthew Paul (VP, Legal and Secretary) has filed a Form 4 on PROTEON THERAPEUTICS INC|
Txns:
| Granted 60,000 options to buy
@ $2.64, valued at
$158.4k
|
|
| 01/03/2019 |
4
| Kowalsky Matthew Paul (VP, Legal and Secretary) has filed a Form 4 on PROTEON THERAPEUTICS INC|
Txns:
| Granted 2,448 shares
@ $1.93, valued at
$4.7k
|
|
| 07/03/2018 |
4
| Kowalsky Matthew Paul (VP, Legal and Secretary) has filed a Form 4 on PROTEON THERAPEUTICS INC|
Txns:
| Granted 10,000 shares
@ $1.615, valued at
$16.2k
|
|
| 01/18/2018 |
4
| Kowalsky Matthew Paul (VP, Legal and Secretary) has filed a Form 4 on PROTEON THERAPEUTICS INC|
Txns:
| Granted 110,000 options to buy
@ $2.85, valued at
$313.5k
|
|
| 01/03/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/05/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
|
|